Humoral and cellular response to the third COVID-19 vaccination in patients with inborn errors of immunity or mannose-binding lectin deficiency : A prospective controlled open-label trial.
Vossen MG, Kartnig F, Mrak D, Simader E, Stiasny K, Kain R, Perkmann T, Haslacher H, Aberle JH, Heinz LX, Sieghart D, Burgmann H, Aletaha D, Scheinecker C, Bonelli M, Göschl L.
Vossen MG, et al.
Wien Klin Wochenschr. 2024 Nov;136(21-22):598-607. doi: 10.1007/s00508-024-02459-6. Epub 2024 Oct 24.
Wien Klin Wochenschr. 2024.
PMID: 39446203
Free PMC article.
Clinical Trial.
In this prospective open-label clinical trial, we assessed the humoral immune response and the T-cell response in patients with IEI or severe MBL (mannose-binding lectin) deficiency (IEI/MBLdef) after three vaccinations. A total of 16 patients and 16 m …
In this prospective open-label clinical trial, we assessed the humoral immune response and the T-cell response in patients with IEI or sever …